Milpro 2.5 mg/25 mg Film-coated Tablets for Small Dogs and Puppies

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Ingrédients actifs:

Milbemycin Oxime (A3 and A4), Praziquantel

Disponible depuis:

Virbac

Code ATC:

QP54AB51

DCI (Dénomination commune internationale):

Milbemycin Oxime (A3 and A4), Praziquantel

forme pharmaceutique:

Tablet

Type d'ordonnance:

POM-V - Prescription Only Medicine – Veterinarian

Groupe thérapeutique:

Dogs

Domaine thérapeutique:

Anthelmintic

Statut de autorisation:

Authorized

Date de l'autorisation:

2014-07-15

Résumé des caractéristiques du produit

Revised: September 2021
AN: 02228/2020 & 02229/2020
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Milpro 2.5 mg/25 mg film-coated tablets for small dogs and puppies
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Milbemycin oxime
2.5 mg
Praziquantel
25 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Oval shaped, beige to pale brown, meat flavoured tablets with a score
on both sides.
The tablets can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs (small dogs and puppies).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In dogs: treatment of mixed infections by adult cestodes (tapeworms)
and nematodes
(roundworms) of the following species:
Cestodes:
_Dipylidium caninum,_
_Taenia _spp.,
_Echinococcus _spp.,
_Mesocestoides _spp.
Nematodes:
_Ancylostoma caninum,_
_Toxocara canis,_
_Toxascaris leonina,_
_Trichuris vulpis,_
_Thelazia _
_callipaeda_
(see
specific
treatment
schedules
under
section
4.9
“Amounts to be administered and administration route”),
_Crenosoma vulpis_ (Reduction of the level of infection),
_Angiostrongylus vasorum_ (Reduction of the level of infection by
immature adult
(L5) and adult parasite stages; see specific treatment and disease
prevention
schedules under section “4.9 Amounts to be administered and
administration
route”).
The product can also be used in the prevention of heartworm disease
(_Dirofilaria _
_immitis_), if concomitant treatment against cestodes is indicated.
Revised: September 2021
AN: 02228/2020 & 02229/2020
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not use in puppies of less than 2 weeks of age and/or weighing less
than 0.5 kg.
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
See also point "Special precautions for use".
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In
order
to
develop
an
effective
worm
control
programme
local
epidemiological
information and the